No results for ‘’
GKB Ophthalmics Ltd
NSE: GKB BSE: 533212
â‚ą64.79
(0.46%)
Tue, 15 Sept 2026, 10:22 am
Market Cap (in Cr)32.11
PE Ratio10.07
Dividend0
Health Technology
Medical Specialties
24.5KGKB Ophthalmics Analysis
dividend
- Unable to calculate sustainability of dividends as GKB Ophthalmics has not reported any payouts.
- Unable to evaluate GKB Ophthalmics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate GKB Ophthalmics's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- GKB Ophthalmics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- GKB Ophthalmics has been profitable on average in the past, therefore cash runway is not a concern.
- GKB Ophthalmics has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 4.3x debt.
- GKB Ophthalmics's cash and other short term assets cover its long term commitments.
- GKB Ophthalmics's level of debt (28.5%) compared to net worth is satisfactory (less than 40%).
- Debt is not well covered by operating cash flow (14.6%, less than 20% of total debt).
- The level of debt compared to net worth has increased over the past 5 years (24.4% vs 28.5% today).
- High level of physical assets or inventory.
management
- The tenure for the GKB Ophthalmics board of directors is about average.
- Krishna's remuneration is about average for companies of similar size in India.
- Krishna's compensation has increased whilst company is loss making.
misc
- GKB Ophthalmics is not covered by any analysts.
- GKB Ophthalmics has significant price volatility in the past 3 months.
past
- Unable to compare GKB Ophthalmics's 1-year earnings growth to the 5-year average as it is not currently profitable.
- GKB Ophthalmics does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- GKB Ophthalmics used its assets less efficiently than the IN Medical Equipment industry average last year based on Return on Assets.
- It is difficult to establish if GKB Ophthalmics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if GKB Ophthalmics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare GKB Ophthalmics's 1-year growth to the IN Medical Equipment industry average as it is not currently profitable.
value
- GKB Ophthalmics is good value based on assets compared to the IN Medical Equipment industry average.
- GKB Ophthalmics is loss making, we can't compare its value to the IN Medical Equipment industry average.
- GKB Ophthalmics is loss making, we can't compare the value of its earnings to the India market.
- 533212 underperformed the Medical Equipment industry which returned 60.7% over the past year.
- 533212 underperformed the Market in India which returned -14.5% over the past year.
- BSE:533212 is down -5.5% underperforming the Medical Equipment industry which returned 9.6% over the past month.
- BSE:533212 is down -5.5% underperforming the market in India which returned 8% over the past month.